PremiumCompany AnnouncementsSera Prognostics Earnings Call: Balancing Success and Challenges Sera Prognostics Reports 2024 Financial Results and Strategic Plans Closing Bell Movers: Five Below up 10% after Q4 beat PremiumThe FlySera Prognostics announces Class A common stock offering Sera Prognostics Highlights PreTRM Test in Investor Update Sera Prognostics Highlights PreTRM® at Healthcare Conference PremiumThe FlySera Prognostics Inc trading resumes Sera Prognostics Inc trading halted, volatility trading pause Sera Prognostics’ PreTRM test reduces neonatal morbidity, mortality by 18%